Preliminary 2024 MY Clinical Quality Measure Results for Medical Group Review
This is your official opportunity to review and comment on the preliminary clinical quality performance measure results for your medical group. This email includes information on the data review, comment, and appeal process.
2024 dates of service are reflected in these results unless
otherwise noted.
Measures and Reporting
The following measures are included in this review:
- Adolescent Mental Health and/or Depression Screening
- Colorectal Cancer Screening
- Depression Care 6- and 12-month Outcome Measures – Adult Population^
- Depression PHQ-9/PHQ-9M Utilization – Adult Population*
- Depression Care 6- and 12-month Outcome Measures – Adolescent Population^
- Depression PHQ-9/PHQ-9M Utilization – Adolescent Population*
- Optimal Asthma Control – Adult Population
- Optimal Asthma Control – Child Population
- Optimal Diabetes Care
- Optimal Vascular Care
^Denominator Identification Period 11/01/2022 - 10/31/2023, with follow-up through 12/30/2024
*Measurement Period 09/01/2024-12/31/2024.
Measures are reported at the clinic and medical group levels. They are calculated from data extracted and submitted by clinics and are independently validated by MN Community Measurement (MNCM). Measures that are part of MNCM’s measure reporting slate are included in this review.
Results Review and Public Reporting
Data files are attached to this article. The file
password emailed to contacts at included medical groups. Please note that the results in the data
files are preliminary and are not final until all data validation,
including this review period, are complete. Also, please note that the review
files and results are considered confidential.
This review includes results of clinics and medical groups that participated in the 2024 MY Mid-Year Cycle and that will be publicly reported. To be publicly reported, a clinic must meet data reliability standards by having at least thirty eligible patients. Data from all clinics – both publicly reported and not – are included in the rolled up medical group and statewide rates. Clinics and medical groups that participated in the 2024 MY Regular Cycle reviewed their preliminary results separately.
Performance ratings (e.g., Above Average, Average, Below Average) are not
included in this review but will be available for preview prior to public
reporting of final risk adjusted results.
Comment Process
Comments, questions and other feedback will be accepted until 5:00 p.m. on Tuesday,
November 18 via email at support@mncm.org or phone at 612-746-4522.
Each medical group is responsible for reviewing its own preliminary results,
investigating any concerns, and submitting evidence to MNCM if a
change in results is requested. In that event, MNCM staff will review the
information provided and decide whether to publicly report the
results based upon the evidence submitted.
Appeal Process
If MNCM’s decision does not favor the medical group/clinic, a formal
written appeal may be submitted. Medical groups have two weeks from the date of
the decision to submit a formal appeal. Supporting evidence must be
submitted with the appeal.
Only concerns about publicly reported results are subject to appeal. It is
extremely rare for MNCM to change performance results unless a
medical group/clinic provides evidence of an error, or a pattern of data errors
can be identified by MNCM based on multiple comments. Feedback regarding the
definition of a measure, patient attribution methodology, or other data
collection methods are not subject to appeal; however, it will be forwarded
to the appropriate board committee for review.
Appeals must be submitted in writing (email preferred) to Liz Cinqueonce,
President and CEO of MN Community Measurement (cinqueonce@mncm.org).
The President reviews all appeals and makes recommendations to the MNCM Data
Integrity and Use Committee. The Committee makes final decisions on the
dispensation of appeals.
We appreciate your time in reviewing these results.
Thank you!
MN Community Measurement
